Is Bio-X Diagnostics still active?

Yes, Bio-X Diagnostics is currently active.

Where is Bio-X Diagnostics registered?

Bio-X Diagnostics's registered address is Rue de la Calestienne 38, 5580 Rochefort, Belgium.

How many employees does Bio-X Diagnostics have?

Based on its most recently filed annual accounts (fiscal year ending 31 Aug 2025), Bio-X Diagnostics reported 24.6 full-time equivalent employees.

What is Bio-X Diagnostics's annual turnover?

Bio-X Diagnostics's most recently filed annual turnover (fiscal year ending 31 Aug 2025) was €6,080,783.

Did Bio-X Diagnostics make a profit or a loss?

Bio-X Diagnostics's most recently filed annual accounts (fiscal year ending 31 Aug 2025) reported a profit of €56,097.

When did Bio-X Diagnostics last file annual accounts?

Bio-X Diagnostics's most recently filed annual accounts cover the fiscal year ending 31 Aug 2025.

Is Bio-X Diagnostics B Corp certified?

We have no B Corp certification on file for Bio-X Diagnostics.

Does Bio-X Diagnostics hold Fairtrade certification?

No, Bio-X Diagnostics does not currently hold Fairtrade certification.

Bio-X Diagnostics

Q: When was Bio-X Diagnostics founded?

Bio-X Diagnostics was founded on 23 Apr 1990, making it 36 years old.

Q: What does Bio-X Diagnostics do?

Bio-X Diagnostics's registered main activities are Wholesale of pharmaceutical and medical goods, Wholesale of chemical products for industrial use, Research and experimental development on other natural sciences and engineering, Wholesale trade of medical, surgical and dental supplies, Manufacture of medical and dental instruments and supplies, and Manufacture of composite diagnostic or laboratory reagents.

BE 0441.580.721

Copied!

NV/SA

Status

Active

Founded

23 Apr 1990 · 36 yrs

Size

Small · 24.6 FTE

Legal name

Bio -X Diagnostics

Main activity

Wholesale of pharmaceutical and medical goods

Activities

6 activities

Wholesale of pharmaceutical and medical goodsWholesale of chemical products for industrial useResearch and experimental development on other natural sciences and engineeringWholesale trade of medical, surgical and dental suppliesManufacture of medical and dental instruments and suppliesManufacture of composite diagnostic or laboratory reagents

Financials

Turnover2025

€6.1M+3.1%

Profit / Loss2025

€56.1K-67.9%

Equity2025

€3.6M+0.5%

2025	2024	2023	2022
€6,080,783+3.1%	€5,898,700-2.3%	€6,040,244+0.1%	€6,034,442
€56,097-67.9%	€174,667+55.7%	€112,180-85.1%	€754,253
€3,643,597+0.5%	€3,626,387+3.9%	€3,491,438+1.3%	€3,446,586
€1,539,275-9.9%	€1,708,031-5%	€1,798,709-14.4%	€2,100,462
€136,803-68.4%	€432,349-16.2%	€515,734+48.7%	€346,931
24.6+2.9%	23.9-2.4%	24.5-1.6%	24.9
€247,186+0.2%	€246,808+0.1%	€246,541+1.7%	€242,347

Frequently asked questions

01What is Bio-X Diagnostics's official registered name?

Bio -X Diagnostics.

02What is Bio-X Diagnostics's enterprise number (VAT number)?

BE 0441.580.721.

03What is Bio-X Diagnostics's legal form?

Naamloze vennootschap (NV) / Société anonyme (SA).

04When was Bio-X Diagnostics founded?

Sources

KBO — Kruispuntbank van Ondernemingen

NBB — Nationale Bank van België

Links

Belgian National Gazette — Publications

Check withholding obligation

Central Register of Director Disqualifications

	2025	2024	2023	2022
Income statement
	€6,080,783+3.1%	€5,898,700-2.3%	€6,040,244+0.1%	€6,034,442
	€1,658,954+17.2%	€1,415,686-5.7%	€1,500,599+12.1%	€1,338,210
	€47,515-75%	€189,944+65%	€115,093-37.1%	€182,879
	—	€475,837+14.4%	€415,864-11.4%	€469,401
	—	€464,999	—	—
	€56,097-67.9%	€174,667+55.7%	€112,180-85.1%	€754,253
	€26,622+80.9%	€14,718>1000%	€1,149>1000%	€8
Profitability
	—	8.1%+17.2%	6.9%-11.5%	7.8%
	0.9%-68.8%	3.0%+59.4%	1.9%-85.1%	12.5%
	1.5%-68%	4.8%+49.9%	3.2%-85.3%	21.9%
	1.1%-66.9%	3.3%+54.3%	2.1%-84.4%	13.6%
Solvency
	€5,182,871-2.9%	€5,338,858+0.9%	€5,290,147-4.6%	€5,547,047
	€1,384,916-2.8%	€1,425,531-6.5%	€1,525,020-6.2%	€1,626,057
	€1,150,0500%	€1,150,0500%	€1,150,0500%	€1,150,050
	€3,643,597+0.5%	€3,626,387+3.9%	€3,491,438+1.3%	€3,446,586
	70.3%+3.5%	67.9%+2.9%	66.0%+6.2%	62.1%
	€29,513-85.6%	€205,258-45.8%	€378,744-31.1%	€550,000
	0.01-85.7%	0.06-47.8%	0.11-32%	0.16
	€1,539,275-9.9%	€1,708,031-5%	€1,798,709-14.4%	€2,100,462
	0.42-10.3%	0.47-8.6%	0.52-15.5%	0.61
	7.34-65.3%	21.13+80.5%	11.71-32.1%	17.26
Liquidity
	€136,803-68.4%	€432,349-16.2%	€515,734+48.7%	€346,931
	€1,681,849+16.7%	€1,440,658+1.4%	€1,420,403+6.4%	€1,334,477
	€512,503-14.9%	€602,612+49.3%	€403,685-27.9%	€560,057
	€1,107,604+14.8%	€964,472+13.6%	€849,283-16.1%	€1,012,166
	€1,509,762+8.8%	€1,388,078-1.6%	€1,410,600-9%	€1,550,412
	1.56+6.8%	1.46+5%	1.39-5.1%	1.47
	€979,087-12.8%	€1,122,374+4.9%	€1,069,790+0.2%	€1,068,049
Efficiency
	31 days-17.5%	37 days+52.9%	24 days-28%	34 days
	93 days+14%	81 days+17%	70 days-14.7%	82 days
	181 days+18.8%	152 days-0.4%	153 days+12.2%	136 days
	2.18-9.9%	2.42-2%	2.47	—
Profit appropriation
	€168,422+1.7%	€165,617+5.6%	€156,883+3.7%	€151,274
	€1,118,419+5%	€1,065,127+18.5%	€899,194+9.6%	€820,715

Sources

NBB — Nationale Bank van België

	2025	2024	2023	2022
Income statement
	€6,080,783+3.1%	€5,898,700-2.3%	€6,040,244+0.1%	€6,034,442
	€1,658,954+17.2%	€1,415,686-5.7%	€1,500,599+12.1%	€1,338,210
	€47,515-75%	€189,944+65%	€115,093-37.1%	€182,879
	—	€475,837+14.4%	€415,864-11.4%	€469,401
	—	€464,999	—	—
	€56,097-67.9%	€174,667+55.7%	€112,180-85.1%	€754,253
	€26,622+80.9%	€14,718>1000%	€1,149>1000%	€8
Profitability
	—	8.1%+17.2%	6.9%-11.5%	7.8%
	0.9%-68.8%	3.0%+59.4%	1.9%-85.1%	12.5%
	1.5%-68%	4.8%+49.9%	3.2%-85.3%	21.9%
	1.1%-66.9%	3.3%+54.3%	2.1%-84.4%	13.6%
Solvency
	€5,182,871-2.9%	€5,338,858+0.9%	€5,290,147-4.6%	€5,547,047
	€1,384,916-2.8%	€1,425,531-6.5%	€1,525,020-6.2%	€1,626,057
	€1,150,0500%	€1,150,0500%	€1,150,0500%	€1,150,050
	€3,643,597+0.5%	€3,626,387+3.9%	€3,491,438+1.3%	€3,446,586
	70.3%+3.5%	67.9%+2.9%	66.0%+6.2%	62.1%
	€29,513-85.6%	€205,258-45.8%	€378,744-31.1%	€550,000
	0.01-85.7%	0.06-47.8%	0.11-32%	0.16
	€1,539,275-9.9%	€1,708,031-5%	€1,798,709-14.4%	€2,100,462
	0.42-10.3%	0.47-8.6%	0.52-15.5%	0.61
	7.34-65.3%	21.13+80.5%	11.71-32.1%	17.26
Liquidity
	€136,803-68.4%	€432,349-16.2%	€515,734+48.7%	€346,931
	€1,681,849+16.7%	€1,440,658+1.4%	€1,420,403+6.4%	€1,334,477
	€512,503-14.9%	€602,612+49.3%	€403,685-27.9%	€560,057
	€1,107,604+14.8%	€964,472+13.6%	€849,283-16.1%	€1,012,166
	€1,509,762+8.8%	€1,388,078-1.6%	€1,410,600-9%	€1,550,412
	1.56+6.8%	1.46+5%	1.39-5.1%	1.47
	€979,087-12.8%	€1,122,374+4.9%	€1,069,790+0.2%	€1,068,049
Efficiency
	31 days-17.5%	37 days+52.9%	24 days-28%	34 days
	93 days+14%	81 days+17%	70 days-14.7%	82 days
	181 days+18.8%	152 days-0.4%	153 days+12.2%	136 days
	2.18-9.9%	2.42-2%	2.47	—
Profit appropriation
	€168,422+1.7%	€165,617+5.6%	€156,883+3.7%	€151,274
	€1,118,419+5%	€1,065,127+18.5%	€899,194+9.6%	€820,715

2025

2024

2023

2022

Income statement

€6,080,783+3.1%

€5,898,700-2.3%

€6,040,244+0.1%

€6,034,442

€1,658,954+17.2%

€1,415,686-5.7%

€1,500,599+12.1%

€1,338,210

€47,515-75%

€189,944+65%

€115,093-37.1%

€182,879

—

€475,837+14.4%

€415,864-11.4%

€469,401

—

€464,999

—

€56,097-67.9%

€174,667+55.7%

€112,180-85.1%

€754,253

€26,622+80.9%

€14,718>1000%

€1,149>1000%

€8

Profitability

—

8.1%+17.2%

6.9%-11.5%

7.8%

0.9%-68.8%

3.0%+59.4%

1.9%-85.1%

12.5%

1.5%-68%

4.8%+49.9%

3.2%-85.3%

21.9%

1.1%-66.9%

3.3%+54.3%

2.1%-84.4%

13.6%

Solvency

€5,182,871-2.9%

€5,338,858+0.9%

€5,290,147-4.6%

€5,547,047

€1,384,916-2.8%

€1,425,531-6.5%

€1,525,020-6.2%

€1,626,057

€1,150,0500%

€1,150,050

€3,643,597+0.5%

€3,626,387+3.9%

€3,491,438+1.3%

€3,446,586

70.3%+3.5%

67.9%+2.9%

66.0%+6.2%

62.1%

€29,513-85.6%

€205,258-45.8%

€378,744-31.1%

€550,000

0.01-85.7%

0.06-47.8%

0.11-32%

0.16

€1,539,275-9.9%

€1,708,031-5%

€1,798,709-14.4%

€2,100,462

0.42-10.3%

0.47-8.6%

0.52-15.5%

0.61

7.34-65.3%

21.13+80.5%

11.71-32.1%

17.26

Liquidity

€136,803-68.4%

€432,349-16.2%

€515,734+48.7%

€346,931

€1,681,849+16.7%

€1,440,658+1.4%

€1,420,403+6.4%

€1,334,477

€512,503-14.9%

€602,612+49.3%

€403,685-27.9%

€560,057

€1,107,604+14.8%

€964,472+13.6%

€849,283-16.1%

€1,012,166

€1,509,762+8.8%

€1,388,078-1.6%

€1,410,600-9%

€1,550,412

1.56+6.8%

1.46+5%

1.39-5.1%

1.47

€979,087-12.8%

€1,122,374+4.9%

€1,069,790+0.2%

€1,068,049

Efficiency

31 days-17.5%

37 days+52.9%

24 days-28%

34 days

93 days+14%

81 days+17%

70 days-14.7%

82 days

181 days+18.8%

152 days-0.4%

153 days+12.2%

136 days

2.18-9.9%

2.42-2%

2.47

—

Profit appropriation

€168,422+1.7%

€165,617+5.6%

€156,883+3.7%

€151,274

€1,118,419+5%

€1,065,127+18.5%

€899,194+9.6%

€820,715

Bio-X Diagnostics

Activities

Financials

Frequently asked questions

All locations

All locations